Mel Wickremasinghe (@mwickremas) 's Twitter Profile
Mel Wickremasinghe

@mwickremas

Respiratoryphysician interested in digital healthcare care, ethical AI for health ,lung fibrosis, orchestral music , energy therapy

ID: 2210478652

calendar_today06-12-2013 13:57:34

285 Tweet

234 Followers

252 Following

Mel Wickremasinghe (@mwickremas) 's Twitter Profile Photo

Did the first digital social prescription today at Imperial NHS 💙 for a lung fibrosis outpatient who used the #CIE to view it. A great potential tool for inpatients too @HelenStokesLam Mohammad Al-Ubaydli The Minded Institute Great Digital team Imperial NHS 💙

Mel Wickremasinghe (@mwickremas) 's Twitter Profile Photo

Patients will now benefit from #socialprescribing Imperial NHS 💙 by the immediacy of digital sign posting and geolocation and the holistic prescription for all aspects of their health and wellbeing not just a disease @HelenStokesLam HealthUnlocked

Mel Wickremasinghe (@mwickremas) 's Twitter Profile Photo

Amazing 15 mins of #Yoga and #mindfulness with Heather Mason The Minded Institute via Zoom in docs office for our respiratory juniors and me Imperial NHS 💙 after a difficult week on Manvers Ward St Marys.. much needed and very restorative thank you Heather!

Mel Wickremasinghe (@mwickremas) 's Twitter Profile Photo

A small thing compared to the suffering of many people in this current situation but not being able to give my 88y dad a hug on his birthday was difficult yesterday

Steve Jones (@actionpfsteve) 's Twitter Profile Photo

Chief Medical Officers : UK Interstitial Lung Disease (ILD) patients need to know URGENTLY if we are considered ‘extremely vulnerable’ to Covid-19 and must follow shielding guidance. PLEASE CLARIFY Professor Chris Whitty @CMOWales @cathcalderwood1 @PHE_uk RCP Action for Pulmonary Fibrosis

Steve Jones (@actionpfsteve) 's Twitter Profile Photo

There are 70,000 people living with ILD in the UK. It is unclear whether government guidance on extreme vulnerability and shielding covers ILD patients. As yet, very few patients have been contacted by either the NHS or their GP.

Steve Jones (@actionpfsteve) 's Twitter Profile Photo

50% OF UK IPF PATIENTS ARE DENIED ACCESS TO ANTIFIBROTIC TREATMENT BY NICE RULES. Early stage IPF patients (FVC > 80%) and those with advanced symptoms (FVC>50%) cannot be prescribed. This is grossly unfair and results in worse outcomes and ultimately shorter lives

Leo Varadkar (@leovaradkar) 's Twitter Profile Photo

COVID-19 has accelerated adoption of digital tech in healthcare & lifescience, opening up new possibilities for patients. Discussing how we can seize the opportunity with @JR_MerseyCare Tara Donnelly @EI_TheUK patientMpower Deciphex Serosep Mirai Medical #irelanduktrade

COVID-19 has accelerated adoption of digital tech in healthcare &amp; lifescience, opening up new possibilities for patients. Discussing how we can seize the opportunity with @JR_MerseyCare <a href="/tara_donnelly1/">Tara Donnelly</a>
 @EI_TheUK <a href="/patientMpower/">patientMpower</a>
<a href="/Deciphex/">Deciphex</a> 
Serosep 
<a href="/Mirai_Medical/">Mirai Medical</a>
#irelanduktrade
Eamonn Costello (@eamonncostello) 's Twitter Profile Photo

Thanks @EI_TheUK Marie-Claire Henry Leo Clancy & Leo Varadkar for yesterday's digital healthcare discussion with @NHSX Tara Donnelly. It was great to discuss patientMpower work with Imperial College & Mel Wickremasinghe & how digitalhealth can transform care pathways

patientMpower (@patientmpower) 's Twitter Profile Photo

Big thanks to all the attendees at our DigitalHealth.London showcase today. In particular we'd like to thank Kay Boycott our chair, Our fantastic clinician speakers Laura Lowndes & Mel Wickremasinghe and our inspirational patient speaker Ron Flewett #DigitalHealthLondonTurns5

patientMpower (@patientmpower) 's Twitter Profile Photo

Exciting news! Ethics committee review of our planned clinical trial assessing health economics of remote monitoring in ILD with PI Mel Wickremasinghe has commenced. Fingers crossed for good news! Full update here . #IPF hubs.la/Q019tpSh0

Qureight (@qureight) 's Twitter Profile Photo

Today we announce our IPF Scientific Advisory Board with leading global experts to help us implement our platform technology with a growing number of biopharma partners worldwide Toby Maher Phil Molyneaux Paul Ford, Bill Bradford and Mel Wickremasinghe. qureight.com/news/qureight-…

Today we announce our IPF Scientific Advisory Board with leading global experts to help us implement our platform technology with a growing number of biopharma partners worldwide <a href="/TobyMMaher/">Toby Maher</a> <a href="/drphilmol/">Phil Molyneaux</a> Paul Ford, Bill Bradford and Mel Wickremasinghe.

qureight.com/news/qureight-…
patientMpower (@patientmpower) 's Twitter Profile Photo

<2 weeks until ERS 2022 - so much to look forward to: New pMp data from the #ILD study with lead Mel Wickremasinghe Poster from Wan Lin Ng at partner site Beaumont Hospital on remote early detection of CT-ILD progression Plus new #ILD collaborations See you at stand J.03A in Barcelona!

&lt;2 weeks until ERS 2022 - so much to look forward to:
New pMp data from the #ILD study with lead <a href="/mwickremas/">Mel Wickremasinghe</a> 
Poster from <a href="/wlinng/">Wan Lin Ng</a> at partner site <a href="/Beaumont_Dublin/">Beaumont Hospital</a> on remote early detection of CT-ILD progression
Plus new #ILD collaborations
See you at stand J.03A in Barcelona!
patientMpower (@patientmpower) 's Twitter Profile Photo

Our poster on feasibility of home spirometry in ILD is in Hall 7 right now. The study led by Dr Mel Wickremasinghe, had high patient adherence & acceptability with home spirometry & oximetry on 91% of study days #ERSCongress #ERS2022

Our poster on feasibility of home spirometry in ILD is in Hall 7 right now. The study led by Dr <a href="/mwickremas/">Mel Wickremasinghe</a>, had  high patient adherence &amp; acceptability with home spirometry &amp; oximetry on 91% of study days #ERSCongress #ERS2022
patientMpower (@patientmpower) 's Twitter Profile Photo

Given sensitivity of frequent spirometry in predicting progression of ILDs home spirometry is a realistic and highly valuable alternative to clinic assessment Mel Wickremasinghe #ERS2022 #ERSCongress2022

patientMpower (@patientmpower) 's Twitter Profile Photo

We are delighted to welcome new members to our panel of clinical advisers. Welcome to Dr Ayodeji Adegunsoye, Dr Melissa Lesko, Prof. Jeff Swigris and Dr Melissa Wickremasinghe. Looking forward to great discussions! rb.gy/0j0bw Jeff Swigris Deji Adegunsoye, MD, PhD Mel Wickremasinghe

We are delighted to welcome new members to our panel of clinical advisers. 
Welcome to Dr Ayodeji Adegunsoye, Dr Melissa Lesko, Prof. Jeff Swigris and Dr Melissa Wickremasinghe. 
Looking forward to great discussions!
rb.gy/0j0bw
<a href="/SwigOutFishing/">Jeff Swigris</a> <a href="/drdayjee/">Deji Adegunsoye, MD, PhD</a> <a href="/mwickremas/">Mel Wickremasinghe</a>